MedicationIndicationsComments
ACE inhibitors1,2,26 Patients with hypertension, diabetes mellitus, chronic kidney disease, abnormal left ventricular function, systolic heart failure, or recent MIDecrease mortality rates
Use caution in pregnant women and in patients with angioedema, renovascular disease, or hyperkalemia
Angiotensin receptor blockers1,2,26 Patients in whom ACE inhibitors are not toleratedNo additional benefit vs. ACE inhibitors
Use caution in pregnant women and in patients with angioedema, renovascular disease, or hyperkalemia
Beta blockers1,2,2629 First-line therapy in patients with history of MI, acute coronary syndrome, systolic heart failure, angina pectoris, atrial fibrillation, or atrial flutter
Consider for patients with essential tremor, hyperthyroidism, or migraine
Decrease mortality rates
Use caution in older patients (may increase stroke risk) and in those with bronchospastic disease, second- or third-degree heart block, symptomatic bradycardia, or depression
Calcium channel blockers1,2,2933 Consider for patients whose symptoms are not controlled with or who cannot tolerate beta blockers, and for patients with Raynaud disease
Can be used in patients with angina pectoris, atrial fibrillation, or atrial flutter
Use long-acting nondihydropyridines; avoid short-acting nifedipine
Use caution in patients with second- or third-degree heart block
Nitrates1,2,29 Patients with angina whose symptoms are not controlled with beta blockers or calcium channel blockers can use long-acting nitrates; short-acting nitrates can be used for quick relief of symptomsEvidence lacking on mortality benefit
Use caution in patients with hypotension
Ranolazine (Ranexa)29,3436 Patients with recent MI or stable coronary artery disease
Adjunctive therapy in patients whose symptoms are not controlled with beta blockers or calcium channel blockers, or in whom beta blockers are not tolerated
Does not lower blood pressure
Use caution in patients with impaired liver function and in those taking QT-prolonging medications